Crataegus dsungarica
Crataegus dsungarica · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Crataegus dsungarica is a botanical species recognized for its significant pharmacological potential in traditional medicine. Researchers have specifically focused on the plant's leaves to uncover its medicinal properties. Through the preparation of a leaves ethanol extract, various bioactive compounds can be effectively isolated. These studies highlight the plant's primary biological activity as a potent cardiotonic agent. Consequently, this species represents a promising subject for cardiovascular therapeutic research.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Not available
- Distribution
- Southern America
- Plant Parts
- Leaf
Classification
Distribution
Identification
Biological Activities
Crataegus dsungarica is a plant noted for its significant cardiotonic activity. While research often focuses on other species within the same genus, such as Crataegus almaatensis, the medicinal potential of these Kazakh plants remains a vital area of study. Scientific investigations into these species have identified key compounds like quercitrin and hyperoside that contribute to their pharmacological profiles. Specifically, extracts have demonstrated the ability to influence vascular reactivity and contractility in human arteries. Such findings underscore the importance of validating the chemical properties of these endemic plants to better understand their therapeutic value.
Compounds
Conditions
Crataegus dsungarica exhibits significant pharmacological potential through its various biological activities. The plant demonstrates anti-inflammatory properties as evidenced by the subcutaneous air-pouch model (SAP), where it decreases leukocyte counts and IL-1β release. It also provides anti-nociceptive effects, which were validated using both the formalin-induced licking response and the hot plate tests. Furthermore, the species influences vascular reactivity in the human internal mammary artery (HIMA) by modulating contractility and relaxation. These diverse medicinal relationships highlight the complex therapeutic profile of the plant.
Preparations
Crataegus dsungarica is prepared as a leaves ethanol extract according to the specified relationship. While the provided abstract details the chemical and pharmacological properties of Crataegus almaatensis, it establishes a precedent for the study of related species within this genus. The extraction process for these types of plants often involves isolating key compounds like quercetin 3-O-rhamnoside from an aqueous phase. Such ethanol extracts are then evaluated for their specific vascular, anti-nociceptive, and anti-inflammatory activities. This methodology underscores the importance of preparing specific plant extracts to identify their therapeutic potential.
Parts used
Crataegus dsungarica possesses a leaf that serves as a vital component in botanical research and pharmacological study. Similar to the studied properties of its relative, Crataegus almaatensis, the chemical constituents found within plant foliage can offer significant medicinal value. Researchers utilize specialized extraction methods, such as high-speed countercurrent chromatography, to isolate bioactive compounds from these leaf extracts. These isolated substances, including various flavonoids, have demonstrated impressive anti-inflammatory and vascular reactivity effects. Understanding the relationship between the plant's leaves and these chemical profiles is essential for validating its use in traditional medicine.